These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Zhang J; Cai Y; Xiao T; Lu J; Peng H; Sterling SM; Walsh RM; Rits-Volloch S; Zhu H; Woosley AN; Yang W; Sliz P; Chen B Science; 2021 Apr; 372(6541):525-530. PubMed ID: 33727252 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Yuan M; Huang D; Lee CD; Wu NC; Jackson AM; Zhu X; Liu H; Peng L; van Gils MJ; Sanders RW; Burton DR; Reincke SM; Prüss H; Kreye J; Nemazee D; Ward AB; Wilson IA Science; 2021 Aug; 373(6556):818-823. PubMed ID: 34016740 [TBL] [Abstract][Full Text] [Related]
10. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. Zhu X; Mannar D; Srivastava SS; Berezuk AM; Demers JP; Saville JW; Leopold K; Li W; Dimitrov DS; Tuttle KS; Zhou S; Chittori S; Subramaniam S PLoS Biol; 2021 Apr; 19(4):e3001237. PubMed ID: 33914735 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Nabel KG; Clark SA; Shankar S; Pan J; Clark LE; Yang P; Coscia A; McKay LGA; Varnum HH; Brusic V; Tolan NV; Zhou G; Desjardins M; Turbett SE; Kanjilal S; Sherman AC; Dighe A; LaRocque RC; Ryan ET; Tylek C; Cohen-Solal JF; Darcy AT; Tavella D; Clabbers A; Fan Y; Griffiths A; Correia IR; Seagal J; Baden LR; Charles RC; Abraham J Science; 2022 Jan; 375(6578):eabl6251. PubMed ID: 34855508 [TBL] [Abstract][Full Text] [Related]
12. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Koenig PA; Das H; Liu H; Kümmerer BM; Gohr FN; Jenster LM; Schiffelers LDJ; Tesfamariam YM; Uchima M; Wuerth JD; Gatterdam K; Ruetalo N; Christensen MH; Fandrey CI; Normann S; Tödtmann JMP; Pritzl S; Hanke L; Boos J; Yuan M; Zhu X; Schmid-Burgk JL; Kato H; Schindler M; Wilson IA; Geyer M; Ludwig KU; Hällberg BM; Wu NC; Schmidt FI Science; 2021 Feb; 371(6530):. PubMed ID: 33436526 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. McCallum M; Bassi J; De Marco A; Chen A; Walls AC; Di Iulio J; Tortorici MA; Navarro MJ; Silacci-Fregni C; Saliba C; Sprouse KR; Agostini M; Pinto D; Culap K; Bianchi S; Jaconi S; Cameroni E; Bowen JE; Tilles SW; Pizzuto MS; Guastalla SB; Bona G; Pellanda AF; Garzoni C; Van Voorhis WC; Rosen LE; Snell G; Telenti A; Virgin HW; Piccoli L; Corti D; Veesler D Science; 2021 Aug; 373(6555):648-654. PubMed ID: 34210893 [TBL] [Abstract][Full Text] [Related]
14. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion. Salleh MZ; Derrick JP; Deris ZZ Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045 [TBL] [Abstract][Full Text] [Related]
15. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody. Yin W; Xu Y; Xu P; Cao X; Wu C; Gu C; He X; Wang X; Huang S; Yuan Q; Wu K; Hu W; Huang Z; Liu J; Wang Z; Jia F; Xia K; Liu P; Wang X; Song B; Zheng J; Jiang H; Cheng X; Jiang Y; Deng SJ; Xu HE Science; 2022 Mar; 375(6584):1048-1053. PubMed ID: 35133176 [TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Saville JW; Mannar D; Zhu X; Srivastava SS; Berezuk AM; Demers JP; Zhou S; Tuttle KS; Sekirov I; Kim A; Li W; Dimitrov DS; Subramaniam S Nat Commun; 2022 Feb; 13(1):742. PubMed ID: 35136050 [TBL] [Abstract][Full Text] [Related]
17. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Xue S; Han Y; Wu F; Wang Q Protein Cell; 2024 May; 15(6):403-418. PubMed ID: 38442025 [TBL] [Abstract][Full Text] [Related]
20. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Wang L; Zhou T; Zhang Y; Yang ES; Schramm CA; Shi W; Pegu A; Oloniniyi OK; Henry AR; Darko S; Narpala SR; Hatcher C; Martinez DR; Tsybovsky Y; Phung E; Abiona OM; Antia A; Cale EM; Chang LA; Choe M; Corbett KS; Davis RL; DiPiazza AT; Gordon IJ; Hait SH; Hermanus T; Kgagudi P; Laboune F; Leung K; Liu T; Mason RD; Nazzari AF; Novik L; O'Connell S; O'Dell S; Olia AS; Schmidt SD; Stephens T; Stringham CD; Talana CA; Teng IT; Wagner DA; Widge AT; Zhang B; Roederer M; Ledgerwood JE; Ruckwardt TJ; Gaudinski MR; Moore PL; Doria-Rose NA; Baric RS; Graham BS; McDermott AB; Douek DC; Kwong PD; Mascola JR; Sullivan NJ; Misasi J Science; 2021 Aug; 373(6556):. PubMed ID: 34210892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]